RSV lower respiratory tract infection prevention
Vaccines · 2024–2024
1decision
1medicine
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| respiratory syncytial virus vaccine, recombinant pre-fusion F protein Prevention of lower respiratory tract illness (LRTI) caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age by active… | May 2024 | Recommended | input received |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.